sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Potential Analysis of Human DNA Vaccines Market by Forecast Scenario Analysis (Rapid Growth Scenario, Moderate Growth Scenario, and Low Growth Scenario) - Global Opportunity Analysis and Industry Forecast, 2020-2030

Potential Analysis of Human DNA Vaccines Market by Forecast Scenario...

Home / Categories / Healthcare
Potential Analysis of Human DNA Vaccines Market by Forecast Scenario Analysis (Rapid Growth Scenario, Moderate Growth Scenario, and Low Growth Scenario) - Global Opportunity Analysis and Industry Forecast, 2020-2030
Potential Analysis of Human DNA...
Report Code
RO1/113/1201

Publish Date
01/Jun/2017

Pages
120
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
DNA vaccines are third-generation vaccines and consist of a small circular piece (DNA sequence) of bacterial DNA, which is used for the immunization. DNA vaccine is used for protecting humans against disease by injecting them with genetically engineered DNA to produce an immunological response by activating the host against the gene delivered. DNA vaccines are advantageous over traditional vaccines as the expression of native virus with the antigen is more similar as compared to conventional vaccines, and several antigen or proteins can be delivered in a single dose. In addition, large-scale production can be carried out at a cost lower than conventional method of vaccines. The global potential analysis of DNA vaccines market is expected to account $3,762 million in 2020 and reach $9,337 million by 2030, growing at a CAGR of 9.5% from 2020 to 2030.


The global potential analysis of human DNA vaccine market is segmented based on forecast scenario analysis and region. Based on forecast scenario analysis, it is divided into rapid growth scenario, moderate growth scenario, and low growth scenario. The market analysis based on region includes North America, Europe, Asia-Pacific, and LAMEA.


KEY MARKET BENEFITS



In-depth study of the global potential market for DNA vaccines is conducted based on the current disease prevalence, target population, and pricing for generating market size and forecast from 2020 to 2030.

Potential analysis of opportunities is evaluated to understand different aspects of DNA vaccines that are currently under various phases of clinical trials along with the variants that would gain prominence in the future.

Vaccine pipeline products against DNA, which are under various clinical stages, are covered.

Key market players are profiled and their strategies are analyzed thoroughly to understand various technologies adopted to manufacture DNA vaccines.



KEY MARKET SEGMENTS


By Forecast Scenario Analysis



Rapid Growth Scenario

Moderate Growth Scenario

Low Growth Scenario



By Region



North America

Europe

Asia-Pacific

LAMEA



KEY PLAYERS



Inovio Pharmaceuticals, Inc.

GeneOne Life Science Inc.

MedImmune

Immunomic Therapeutics, Inc.

Astellas Pharma, Inc.

Pharos Biologicals

Sanofi S.A.

F. Hoffmann-La Roche AG

CureVac

Boehringer Ingelheim GmbH

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com